Currently, there are 186.37M common shares owned by the public and among those 172.48M shares have been available to trade.
The company’s stock has a 5-day price change of 38.99% and 70.80% over the past three months. IREN shares are trading 88.95% year to date (YTD), with the 12-month market performance up to 179.13% higher. It has a 12-month low price of $3.56 and touched a high of $15.75 over the same period. IREN has an average intraday trading volume of 16.60 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 26.26%, 41.73%, and 63.92% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Iris Energy Ltd (NASDAQ: IREN) shares accounts for 29.11% of the company’s 186.37M shares outstanding.
It has a market capitalization of $2.77B and a beta (3y monthly) value of 3.48. The earnings-per-share (ttm) stands at -$0.41. Price movements for the stock have been influenced by the stock’s volatility, which stands at 13.16% over the week and 11.02% over the month.
Analysts forecast that Iris Energy Ltd (IREN) will achieve an EPS of 0.12 for the current quarter, 0.36 for the next quarter and 2.72 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.12 while analysts give the company a high EPS estimate of 0.12. Comparatively, EPS for the current quarter was 0.08 a year ago. Earnings per share for the fiscal year are expected to increase by 237.99%, and 231.11% over the next financial year.
Looking at the support for the IREN, a number of firms have released research notes about the stock. ROTH MKM stated their Buy rating for the stock in a research note on October 02, 2024, with the firm’s price target at $14. Bernstein was of a view on July 10, 2024 that the stock is Outperform, while Cantor Fitzgerald gave the stock Overweight rating on June 11, 2024, issuing a price target of $23. JP Morgan on their part issued Overweight rating on October 11, 2023.
